Nektar Therapeutics NKTR
NASDAQ NKTR
$60.99 +1.75 (+2.95%)
As of: Sep 30, 2026 · 3:52 PM EDT

Nektar Therapeutics (NKTR) EV to EBITDA (2015 - 2019)

Updated

Nektar Therapeutics' (NKTR) EV to EBITDA was 6.71 for Q1 2019, up 7.3% from the prior quarter.

Analysis

Nektar Therapeutics (NKTR) EV to EBITDA (2015 - 2019) Analysis & Trends

Over the twelve months ended Mar 31, 2019, Nektar Therapeutics' EV to EBITDA came in at -0.17; for FY2018, it came in at 6.25.

  • Five-year quarterly EV to EBITDA spans a low of 6.25 in Q4 2018 and a high of 25.60 in Q2 2015.
  • Per Business Quant data, the three quarters before Q1 2019 came in at 6.25 (Q4 2018), 11.79 (Q3 2018) and 6.99 (Q2 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Nektar Therapeutics 1.96 Bn 189.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 6.71
Dec 31, 2018 6.25
Sep 30, 2018 11.79
Jun 30, 2018 6.99
Jun 30, 2015 25.60
Mar 31, 2015 15.15
API Access

Nektar Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=NKTR&period=max&api_key=YOUR_API_KEY